Hong et al. [35] measured the pretreatment serum level of survivin in 210 DLBCL patients and analyzed its association with survival outcome and EBV status, as represented by EBV-encoded RNA (EBER) in DLBCL. This evidence concerns the gene BIRC5 and diffuse large B-cell lymphoma.